324 related articles for article (PubMed ID: 29106825)
1. Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype.
Lamers IJC; Reijnders MRF; Venselaar H; Kraus A; ; Jansen S; de Vries BBA; Houge G; Gradek GA; Seo J; Choi M; Chae JH; van der Burgt I; Pfundt R; Letteboer SJF; van Beersum SEC; Dusseljee S; Brunner HG; Doherty D; Kleefstra T; Roepman R
Am J Hum Genet; 2017 Nov; 101(5):824-832. PubMed ID: 29106825
[TBL] [Abstract][Full Text] [Related]
2. Brain white matter abnormalities associated with copy number variants.
Vigdorovich N; Ben-Sira L; Blumkin L; Precel R; Nezer I; Yosovich K; Cross Z; Vanderver A; Lev D; Lerman-Sagie T; Zerem A
Am J Med Genet A; 2020 Jan; 182(1):93-103. PubMed ID: 31622028
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform.
Scapin SM; Carneiro FR; Alves AC; Medrano FJ; Guimarães BG; Zanchin NI
J Struct Biol; 2006 Jun; 154(3):260-8. PubMed ID: 16545962
[TBL] [Abstract][Full Text] [Related]
4. De Novo Variants in RAB11B Cause Various Degrees of Global Developmental Delay and Intellectual Disability in Children.
Ahmad N; Fazeli W; Schließke S; Lesca G; Gokce-Samar Z; Mekbib KY; Jin SC; Burton J; Hoganson G; Petersen A; Gracie S; Granger L; Bartels E; Oppermann H; Kundishora A; Till M; Milleret-Pignot C; Dangerfield S; Viskochil D; Anderson KJ; Palculict TB; Schnur RE; Wentzensen IM; Tiller GE; Kahle KT; Kunz WS; Burkart S; Simons M; Sticht H; Abou Jamra R; Neuser S
Pediatr Neurol; 2023 Nov; 148():164-171. PubMed ID: 37734130
[TBL] [Abstract][Full Text] [Related]
5. Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive exocytosis.
Khvotchev MV; Ren M; Takamori S; Jahn R; Südhof TC
J Neurosci; 2003 Nov; 23(33):10531-9. PubMed ID: 14627637
[TBL] [Abstract][Full Text] [Related]
6. De novo mutations in the GTP/GDP-binding region of RALA, a RAS-like small GTPase, cause intellectual disability and developmental delay.
Hiatt SM; Neu MB; Ramaker RC; Hardigan AA; Prokop JW; Hancarova M; Prchalova D; Havlovicova M; Prchal J; Stranecky V; Yim DKC; Powis Z; Keren B; Nava C; Mignot C; Rio M; Revah-Politi A; Hemati P; Stong N; Iglesias AD; Suchy SF; Willaert R; Wentzensen IM; Wheeler PG; Brick L; Kozenko M; Hurst ACE; Wheless JW; Lacassie Y; Myers RM; Barsh GS; Sedlacek Z; Cooper GM
PLoS Genet; 2018 Nov; 14(11):e1007671. PubMed ID: 30500825
[TBL] [Abstract][Full Text] [Related]
7. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
8. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
Cai S; Li J; Wu Y; Jiang Y
J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
Zhang B; Zhang Y; Shacter E; Zheng Y
Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
[TBL] [Abstract][Full Text] [Related]
10. De Novo Variants in LMNB1 Cause Pronounced Syndromic Microcephaly and Disruption of Nuclear Envelope Integrity.
Cristofoli F; Moss T; Moore HW; Devriendt K; Flanagan-Steet H; May M; Jones J; Roelens F; Fons C; Fernandez A; Martorell L; Selicorni A; Maitz S; Vitiello G; Van der Hoeven G; Skinner SA; Bollen M; Vermeesch JR; Steet R; Van Esch H
Am J Hum Genet; 2020 Oct; 107(4):753-762. PubMed ID: 32910914
[TBL] [Abstract][Full Text] [Related]
11. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic control of GTP and GDP binding in the oncoprotein p21ras.
Muegge I; Schweins T; Langen R; Warshel A
Structure; 1996 Apr; 4(4):475-89. PubMed ID: 8740369
[TBL] [Abstract][Full Text] [Related]
13. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
14. A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.
Heide EC; Puk O; Biskup S; Krahn A; Rauf E; Kreilkamp BAK; Paulus W; Focke NK
Am J Med Genet A; 2021 Dec; 185(12):3838-3843. PubMed ID: 34327820
[TBL] [Abstract][Full Text] [Related]
15. Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
Petrovski S; Küry S; Myers CT; Anyane-Yeboa K; Cogné B; Bialer M; Xia F; Hemati P; Riviello J; Mehaffey M; Besnard T; Becraft E; Wadley A; Politi AR; Colombo S; Zhu X; Ren Z; Andrews I; Dudding-Byth T; Schneider AL; Wallace G; ; Rosen ABI; Schelley S; Enns GM; Corre P; Dalton J; Mercier S; Latypova X; Schmitt S; Guzman E; Moore C; Bier L; Heinzen EL; Karachunski P; Shur N; Grebe T; Basinger A; Nguyen JM; Bézieau S; Wierenga K; Bernstein JA; Scheffer IE; Rosenfeld JA; Mefford HC; Isidor B; Goldstein DB
Am J Hum Genet; 2016 May; 98(5):1001-1010. PubMed ID: 27108799
[TBL] [Abstract][Full Text] [Related]
16. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
[TBL] [Abstract][Full Text] [Related]
17. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
18. Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation.
McCray BA; Skordalakes E; Taylor JP
Hum Mol Genet; 2010 Mar; 19(6):1033-47. PubMed ID: 20028791
[TBL] [Abstract][Full Text] [Related]
19. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype.
Zou F; McWalter K; Schmidt L; Decker A; Picker JD; Lincoln S; Sweetser DA; Briere LC; Harini C; ; Marsh E; Medne L; Wang RY; Leydiker K; Mower A; Visser G; Cuppen I; van Gassen KL; van der Smagt J; Yousaf A; Tennison M; Shanmugham A; Butler E; Richard G; McKnight D
J Neurogenet; 2017; 31(1-2):30-36. PubMed ID: 28460589
[TBL] [Abstract][Full Text] [Related]
20. The activation cycle of Rab GTPase Ypt32 reveals structural determinants of effector recruitment and GDI binding.
Sultana A; Jin Y; Dregger C; Franklin E; Weisman LS; Khan AR
FEBS Lett; 2011 Nov; 585(22):3520-7. PubMed ID: 22024479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
